Apollo Hospitals Enterprise Limited share price

Apollo Hospitals Enterprise Limited, together with its subsidiaries, provides healthcare services in India. It operates through Healthcare Services, Retail Health & Diagnostics, Digital Health & Pharmacy Distribution, and Others segments. The company's healthcare facilities comprise primary, secondary, and tertiary care, as well as specialty facilities. It offers services in cardiac sciences, oncology, neurosciences, gastroenterology, orthopedics, urology, organ transplantation, pulmonology, obstetrics and gynecology, internal medicine, vascular surgery, pediatrics, cosmetology, emergency medicine, bariatric surgery, general surgery, colorectal surgery, dentistry, nephrology, dermatology, e…Read more

Website NSE हिंदी में BSE

HealthcareMedical Care FacilitiesNifty 50 Nifty 100 Nifty 500NSE: APOLLOHOSPISIN INE437A01024

16 Oct 2026, 3:28 PM IST₹7,890.00▲ 0.50 (0.01%)

Market Cap₹ 1,13,446 Cr.
Current Price₹ 7,890.00
High / Low₹ 9,071 / 6,697
Stock P/E54.3
Book Value₹ 659
Dividend Yield0.25 %
ROCE19.2 %
ROE21.90 %
Face Value₹ 5.0

More figures (10)

EPS (TTM)₹ 145.26
Price / Book11.97
OPM11.7 %
Debt / Equity0.90
Sales growth (5Y)19.0 %
Profit growth (5Y)71.1 %
Promoter holding28.4 %
EV / EBITDA32.6
Beta0.18
All-time high₹ 9,071

Price chart

Price on NSE 50 DMA 200 DMA Volume

Returns	1M	3M	6M	YTD	1Y	3Y CAGR	5Y CAGR
APOLLOHOSP	-9.27%	-11.23%	+4.46%	+12.03%	+0.72%	+16.25%	+12.76%
Nifty 50	-0.31%	-3.85%	-4.34%	-11.42%	-9.53%	+5.46%	+4.76%

Price returns only (dividends not included). Prices from NSE via Yahoo Finance; may be delayed.

Quick take

Apollo Hospitals Enterprise Limited is in the Medical Care Facilities industry (Healthcare), with a market value of ₹1,13,446 crore.
It trades at 54.3 times its last 12 months' earnings and 12.0 times book value.
Revenue grew 19.0% a year over the last 5 years, profit 71.1% a year.
Return on equity was 21.9% and return on capital employed 19.2% in the latest year.
Debt was 0.90 times shareholders' equity.
The share price is 13.0% below its 52-week high and up 0.7% over one year.
Promoters and insiders hold about 28.4%; institutions about 50.8%.

Pros

Strong return on equity: 18.2% on average over the last 3 years.
Sales have grown 19.0% a year over the last 5 years.
Profit has grown 71.1% a year over the last 5 years.
Latest quarter (Jun 2026): sales up 21% and profit up 38% from a year ago.
Trades at 54.3 times earnings, below its 3-year median of 292.9.

Cons

Trades at 12.0 times its book value.

Pros and cons are generated automatically from the reported figures. They are observations, not a recommendation to buy or sell.

AI analysis

Plenitude AI reads the figures on this page and explains them in plain language. It does not say whether to buy or sell.

About Apollo Hospitals Enterprise Limited

Employees: 44,008
Head office: Chennai
NSE industry: Healthcare

HealthcareHealthcareMedical Care Facilities

Part ofNifty 50 Nifty 100 Nifty 500

S.No.	Company	CMP ₹	P/E	Mar Cap ₹ Cr	Div Yld %	NP Qtr ₹ Cr	Qtr Profit Var %	Sales Qtr ₹ Cr	Qtr Sales Var %	ROCE %	ROE %	P/B	OPM %	Debt / Eq	Prom. Hold. %	Sales ₹ Cr	Sales Var 3Yrs %
1.	Apollo Hospitals Enterprise	7,890.00	54.3	1,13,446	0.25	610	38.41	7,044	20.56	19.2	21.9	11.97	11.7	0.90	28.39	25,229	19.0
2.	Max Healthcare Institute	846.00	56.7	82,342	0.23	323	4.87	2,366	16.70	12.6	14.3	7.66	22.8	0.32	28.20	8,225	22.4
3.	Aster DM Quality Care	674.35	109.3	58,781	0.44	29	-68.70	1,311	21.60	9.4	9.7	7.59	14.2	0.49	64.26	4,643	15.7
4.	Fortis Healthcare	736.50	53.1	55,603	0.13	266	2.35	2,545	17.46	11.9	11.1	5.62	17.8	0.35	35.19	9,048	13.3
5.	Narayana Hrudayalaya	1,719.40	42.5	34,921	0.26	207	5.37	2,684	78.05	11.4	19.7	7.70	15.5	1.29	67.23	7,896	20.5
6.	Global Health	1,240.00	60.0	33,322	0.04	159	-0.18	1,304	26.50	15.0	15.1	8.41	16.8	0.30	66.39	4,318	17.2
7.	Krishna Institute of Medical Sciences	685.60	134.4	28,796	0.00	42	-47.20	1,180	35.33	8.1	11.0	12.21	13.8	1.89	41.74	3,872	21.3
8.	Rainbow Children's Medicare	1,248.90	44.4	12,634	0.28	63	16.23	470	33.17	16.8	17.9	7.69	23.7	0.54	52.29	1,703	13.1
9.	Park Medi World	235.70	35.9	10,181	0.00	83	42.30	476	19.27	17.9	16.8	4.64	23.3	0.18	83.94	1,651	9.6
10.	HealthCare Global Enterprises	588.20	379.5	8,782	0.00	14	189.89	693	13.34	6.7	1.2	6.39	8.8	1.30	70.64	2,522	14.6
	Median: 15 Co.	791.25	53.7	12,634	0.13	121	5.12	1,307	21.08	12.3	15.1	7.66	15.5	0.52	58.28	4,481	17.2

Companies in the same industry; the median covers every company in it that we hold figures for. Tap a heading to sort. Sorting and comparing are ways to explore data, not recommendations.

Quarterly Results

Consolidated figures in ₹ crore /

₹ Cr	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	4,418	4,847	4,851	4,944	5,086	5,589	5,527	5,592	5,842	6,304	6,477	6,606	7,044
YOY Sales Growth %	16.39%	14.02%	13.77%	14.92%	15.12%	15.32%	13.94%	13.11%	14.88%	12.78%	17.20%	18.12%	20.56%
	3,909	4,219	4,237	4,303	4,411	4,774	4,765	4,823	4,990	5,362	5,512	5,595	5,951
Material Cost %	51%	51%	52%	51%	52%	51%	52%	52%	52%	51%	52%	52%	51%
Employee Cost %	13%	13%	13%	13%	13%	13%	12%	13%	12%	12%	12%	12%	11%
Other Expenses %	24%	23%	22%	23%	22%	22%	21%	21%	21%	21%	21%	22%	22%
Operating Profit	509	628	614	641	675	816	762	770	852	941	965	1,011	1,092
OPM %	12%	13%	13%	13%	13%	15%	14%	14%	15%	15%	15%	15%	16%
	28	22	28	28	37	38	64	61	40	55	53	44	49
Exceptional items		2									-19
Interest	106	111	113	119	116	118	110	115	108	110	113	119	120
Depreciation	167	163	167	190	177	185	185	211	215	218	219	224	235
Profit before tax	264	377	362	360	419	552	531	505	569	668	667	711	785
	37%	35%	30%	31%	27%	29%	30%	20%	25%	27%	25%	24%	24%
Current tax	102	133	113	89	113	160	135	119	125	162	147	196	210
Deferred tax	-6	-2	-4	21	2	2	22	-18	17	19	19	-26	-22
	173	249	254	258	316	396	379	415	441	494	516	551	610
Profit from associates	6	2	1	9	12	6	5	11	14	6	15	10	13
Minority share	7	16	9	5	10	17	7	25	8	17	14	22	30
Profit to shareholders	167	233	245	254	305	379	372	390	433	477	502	529	581
YOY Profit Growth %	-46.45%	16.90%	56.74%	77.42%	81.95%	59.04%	49.14%	60.41%	39.78%	24.84%	36.08%	33.00%	38.41%
EPS in Rs	2.90	4.05	4.27	4.41	5.31	6.59	6.47	6.78	15.05	16.60	34.94	36.82	40.39
Raw filing

₹ Cr	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	1,688	1,867	1,824	1,895	1,937	2,135	2,055	2,075	2,168	2,356	2,364	2,439	2,656
YOY Sales Growth %	10.38%	8.80%	11.32%	15.47%	14.70%	14.41%	12.63%	9.54%	11.94%	10.34%	15.03%	17.50%	22.52%
	1,271	1,387	1,374	1,444	1,466	1,595	1,543	1,554	1,622	1,763	1,770	1,843	2,000
Material Cost %	27%	28%	27%	28%	28%	27%	28%	27%	27%	26%	26%	25%	25%
Employee Cost %	20%	19%	19%	20%	20%	19%	19%	20%	19%	18%	17%	18%	17%
Other Expenses %	28%	28%	29%	28%	28%	28%	28%	28%	29%	31%	32%	33%	33%
Operating Profit	418	479	450	450	471	540	512	521	546	593	594	596	656
OPM %	25%	26%	25%	24%	24%	25%	25%	25%	25%	25%	25%	24%	25%
	18	65	52	46	27	121	108	92	33	141	108	90	47
Exceptional items											-11
Interest	61	60	61	69	64	65	62	63	59	58	62	63	68
Depreciation	93	93	97	115	103	108	108	130	123	122	127	128	134
Profit before tax	282	391	344	312	332	488	449	420	397	554	502	494	501
	24%	25%	24%	24%	24%	24%	24%	21%	23%	24%	24%	23%	23%
Current tax	74	104	90	54	81	120	105	99	89	123	107	138	125
Deferred tax	-6	-8	-9	19	-1	-2	3	-13	0	11	12	-26	-9
	214	295	263	239	252	370	342	333	307	420	384	382	385
YOY Profit Growth %	-35.73%	5.59%	7.05%	5.26%	17.56%	25.37%	29.94%	39.61%	21.93%	13.61%	12.27%	14.70%	25.51%
EPS in Rs	3.72	5.13	4.57	4.15	4.38	6.43	5.94	5.80	10.68	14.60	26.67	26.59	26.79
Raw filing

Source: the company's results filed with NSE, as reported. EPS restated for bonus issues and splits. Tap a row marked + for its breakdown. Latest quarter on the right.

Profit & Loss

Consolidated figures in ₹ crore /

₹ Cr	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	8,243	9,617	11,247	10,560	14,663	16,612	19,059	21,794	25,229	26,430
YOY Sales Growth %		16.67%	16.94%	-6.11%	38.85%	13.30%	14.73%	14.35%	15.76%
	7,450	8,554	9,660	9,423	12,478	14,563	16,669	18,772	21,459	22,420
Material Cost %	49%	48%	49%	54%	52%	52%	51%	52%	52%	52%
Employee Cost %	17%	17%	16%	15%	12%	13%	13%	13%	12%	12%
Other Expenses %	24%	24%	21%	20%	21%	23%	23%	22%	21%	22%
Operating Profit	793	1,064	1,587	1,137	2,185	2,050	2,391	3,022	3,769	4,010
OPM %	10%	11%	14%	11%	15%	12%	13%	14%	15%	15%
	32	31	27	45	78	90	106	200	192	200
Exceptional items			198	61	294		2		-19	-19
Interest	295	327	533	449	379	381	449	459	450	462
Depreciation	359	396	620	573	601	615	687	758	876	897
Profit before tax	171	373	660	221	1,578	1,144	1,363	2,006	2,616	2,832
	65%	47%	34%	38%	30%	22%	33%	27%	25%	25%
Current tax	88	126	214	76	238	406	437	526	629
Deferred tax	24	47	11	9	239	-150	9	8	29
	60	200	432	137	1,108	845	935	1,505	2,003	2,172
Profit from associates	0	1	-3	1	7	-43	18	33	45	45
Minority share	-58	-36	-23	-14	53	26	36	59	61	83
Profit to shareholders	117	236	455	150	1,056	819	899	1,446	1,942	2,090
YOY Profit Growth %		236.08%	115.72%	-68.33%	710.38%	-23.80%	10.71%	60.97%	33.06%
EPS in Rs	2.11	4.24	8.18	2.69	18.36	14.24	15.63	25.14	135.04	128.75
Dividend Payout %						31%	24%	19%	15%

Compounded Sales Growth

5 Years:: 19%
3 Years:: 15%
TTM:: 17%

Compounded Profit Growth

5 Years:: 71%
3 Years:: 33%
TTM:: 33%

Stock Price CAGR

5 Years:: 13%
3 Years:: 16%
1 Year:: 1%

Return on Equity

4 Years:: 17%
Last Year:: 22%

₹ Cr	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	7,183	8,337	9,794	9,153	6,098	6,525	7,274	8,202	9,326	9,814
YOY Sales Growth %		16.06%	17.49%	-6.55%	-33.37%	6.99%	11.48%	12.76%	13.71%
	6,353	7,319	8,379	8,206	4,679	4,843	5,476	6,158	6,998	7,376
Material Cost %	53%	52%	53%	59%	32%	29%	27%	27%	26%	25%
Employee Cost %	16%	16%	16%	14%	19%	19%	20%	19%	18%	18%
Other Expenses %	20%	20%	17%	17%	26%	27%	28%	28%	31%	32%
Operating Profit	830	1,018	1,415	947	1,419	1,681	1,798	2,044	2,328	2,438
OPM %	12%	12%	14%	10%	23%	26%	25%	25%	25%	25%
	13	12	11	18	47	152	180	348	372	387
Exceptional items			164	-9	-7				-11	-11
Interest	240	268	426	344	244	239	250	254	242	251
Depreciation	272	300	482	436	363	367	399	449	500	512
Profit before tax	330	462	682	177	852	1,228	1,329	1,689	1,946	2,050
	29%	35%	31%	40%	33%	12%	24%	23%	23%	23%
Current tax	74	111	205	62	40	303	322	406	457
Deferred tax	23	49	7	9	239	-160	-4	-13	-4
	233	303	470	105	665	1,085	1,011	1,296	1,493	1,571
Profit to shareholders	215		470
YOY Profit Growth %		29.83%	55.32%	-77.64%	532.46%	63.12%	-6.85%	28.28%	15.14%
EPS in Rs	4.19	5.44	8.45	1.88	11.57	18.86	17.57	22.54	103.81	94.65
Dividend Payout %						24%	21%	21%	19%

Compounded Sales Growth

5 Years:: 0%
3 Years:: 13%
TTM:: 16%

Compounded Profit Growth

5 Years:: 70%
3 Years:: 11%
TTM:: 16%

Stock Price CAGR

5 Years:: 13%
3 Years:: 16%
1 Year:: 1%

Return on Equity

4 Years:: 17%
Last Year:: 22%

Financial years ending March; TTM = the last four quarters. Source: the company's results filed with NSE, as reported. EPS restated for bonus issues and splits. Tap a row marked + for its breakdown. Dividend payout = dividends paid in the year ÷ net profit.

Balance Sheet

Consolidated figures in ₹ crore, as at 31 March

₹ Cr	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	72	72	72	72
Reserves	6,126	6,864	8,140	9,408
	4,332	5,333	5,419	8,492
Long term borrowings	1,938	2,236	1,972	2,430
Short term borrowings	773	926	858	3,228
	3,898	4,485	7,026	4,224
Trade payables	1,916	2,369	2,241	2,252
Minority interest	334	385	441	494
Current liabilities	3,325	4,665	4,579	6,481
Total Liabilities	14,428	16,753	20,657	22,197
	8,117	9,461	10,739	12,228
Gross block	11,858	13,740	15,613	17,756
Accumulated depreciation	3,741	4,279	4,874	5,528
Goodwill & intangibles	1,092	1,148	1,320	1,272
CWIP	685	921	923	1,190
	5,626	6,371	8,995	8,779
Inventories	390	460	481	542
Trade receivables	2,234	2,515	3,016	3,485
Cash & equivalents	433	506	578	811
Current assets	4,337	5,280	7,029	6,900
Total Assets	14,428	16,753	20,657	22,197

Source: Yahoo Finance (compiled from the annual reports). Tap a row marked + for its breakdown.

Cash Flows

Consolidated figures in ₹ crore, financial years ending March

₹ Cr	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	1,377	1,920	2,136	2,856
Profit for the year	819	899	1,446	1,942
Working capital changes	-450	-193	-604	-574
Direct taxes paid	-382	-467	-486	-606
	-871	-1,537	-3,383	-2,148
Fixed assets purchased	-1,129	-1,137	-1,713	-1,962
Fixed assets sold	4	2	15	31
Investments purchased	-992	-1,257	-3,571	-1,712
Investments sold	1,248	817	1,815	2,684
	-633	-311	1,319	-478
Proceeds from borrowings	585	707	2,585	1,115
Repayment of borrowings	-516	-254	-442	-734
Interest paid	-251	-303	-302	-278
Dividends paid	-255	-216	-273	-288
Net Cash Flow	-127	72	73	230
Free Cash Flow	248	783	424	894

Free cash flow = cash from operations − capital expenditure. Source: Yahoo Finance.

Ratios

Ratio	Mar 2023	Mar 2024	Mar 2025	Mar 2026
ROE	13.2%	13.7%	19.1%	21.9%
ROCE	13.1%	14.8%	15.3%	19.2%
Operating margin	8.8%	9.1%	10.6%	11.7%
Net margin	5.0%	4.8%	6.7%	7.8%
Debt / equity	0.70	0.77	0.66	0.90
Current ratio	1.30	1.13	1.54	1.06
Debtor days	50	49	51	51
Inventory days	17	17	16	15
Days payable	82	88	72	63
Cash conversion cycle	-15	-22	-5	3
Working capital days	22	12	42	6

Computed from the reported statements: ROE on average equity; ROCE = EBIT / (total assets − current liabilities). Debtor days = receivables ÷ sales × 365; inventory and payable days use cost of goods sold; cash conversion cycle = debtor + inventory − payable days; working capital days = (current assets − current liabilities) ÷ sales × 365.

Shareholding Pattern

Numbers in percentages · as filed with NSE each quarter

Promoters 28.02%
FIIs 43.18%
DIIs 22.07%
Government 0.23%
Public 6.49%

%	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	29.33%	29.33%	29.33%	29.33%	29.33%	29.34%	29.34%	28.02%	28.02%	28.02%	28.02%	28.02%
	46.25%	45.63%	43.92%	45.37%	45.27%	42.74%	43.49%	44.20%	43.54%	42.62%	41.50%	43.18%
Foreign portfolio investors (Cat. I)	43.43%	43.05%	41.82%	43.35%	43.34%	41.14%	41.88%	42.82%	42.25%	41.30%	40.16%	41.84%
Foreign portfolio investors (Cat. II)	2.82%	2.58%	2.10%	2.02%	1.93%	1.60%	1.61%	1.38%	1.29%	1.32%	1.33%	1.35%
	18.87%	19.55%	21.14%	19.95%	19.98%	22.29%	21.34%	21.12%	21.51%	22.76%	23.72%	22.07%
Mutual funds	13.92%	14.28%	14.71%	12.80%	12.77%	15.42%	15.94%	16.48%	16.75%	16.65%	17.33%	17.19%
Insurance companies	4.05%	4.24%	5.18%	5.90%	6.02%	5.93%	4.36%	3.46%	3.64%	4.66%	4.85%	3.78%
Banks			0.16%	0.11%		0.19%	0.13%	0.14%	0.17%	0.14%	0.11%	0.09%
Provident & pension funds	0.85%	0.98%	1.04%	1.05%	1.10%	0.64%	0.70%	0.73%	0.77%	0.83%	0.89%	0.84%
Alternative investment funds	0.05%	0.05%	0.04%	0.08%	0.08%	0.11%	0.21%	0.31%	0.17%	0.48%	0.54%	0.17%
Government	0.23%	0.23%	0.23%	0.23%	0.23%	0.23%	0.23%	0.23%	0.23%	0.23%	0.23%	0.23%
	5.32%	5.26%	5.38%	5.12%	5.19%	5.41%	5.61%	6.43%	6.71%	6.37%	6.54%	6.49%
Retail (up to ₹2 lakh)	3.55%	3.60%	3.68%	3.52%	3.56%	3.71%	3.89%	4.34%	4.60%	4.26%	4.30%	4.28%
HNIs (above ₹2 lakh)	0.15%	0.14%	0.13%	0.10%	0.10%	0.10%	0.10%	0.10%	0.10%	0.14%	0.18%	0.18%
NRIs	0.74%	0.73%	0.74%	0.72%	0.73%	0.74%	0.75%	0.78%	0.77%	0.79%	0.79%	0.77%
Bodies corporate	0.38%	0.28%	0.32%	0.26%	0.28%	0.32%	0.34%	0.56%	0.63%	0.61%	0.67%	0.67%
IEPF	0.35%	0.35%	0.35%	0.35%	0.37%	0.37%	0.36%	0.36%	0.39%	0.38%	0.37%	0.37%
No. of Shareholders	1,19,578	1,30,664	1,27,754	1,19,245	1,27,802	1,34,058	1,41,007	1,60,556	1,78,648	1,74,610	1,74,281	1,72,863

Source: shareholding patterns filed by the company with NSE. Public = non-institutional holders. Tap a row marked + for its breakdown.

Mutual funds & institutions holding Apollo Hospitals Enterprise

Holder (above 1%)	Stake
SBI NIFTY 50 ETFMutual fund · see the fund house	2.34%
AXIS MUTUAL FUND TRUSTEE LIMITEDMutual fund · see the fund house	1.77%
ICICI Prudential Balanced Advantage FundMutual fund	1.58%
Hdfc Trustee Company LimitedMutual fund	1.48%
Mirae Asset ELSS Tax Saver FundMutual fund	1.16%
Nippon Life India Trustee LtdMutual fund	1.13%
Kotak Arbitrage FundMutual fund	1.12%
ADITYA BIRLA SUN LIFE MUTUAL FUNDMutual fund · see the fund house	1.07%

As named in the shareholding pattern for Sep 2026 filed with NSE; mutual funds together hold 17.19% of the company. Shareholders below 1% are not named in the filing.

Documents

Announcements

All announcements on NSE →

Annual reports

Credit ratings

Concalls & investor meets

Filings made by the company with NSE; documents open on NSE's website.

Key dates

Results announced: 5 Nov 2026
Ex-dividend date: 14 Aug 2026
Latest quarter: 30 Jun 2026
Financial year end: 31 Mar 2026

Trade with our broking desk

Open a trading & demat account through Parshvanath Investments, Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539; NSE AP0153037862, BSE AP01095201177059). Execution and service only: no tips or research.

Open an account How it works

Latest news

In the news

From the company (NSE)

Headlines from news publishers (via Google News) and the filings of the company with NSE; they open on the source website. Headlines with price targets or buy/sell calls are left out. News is for information only and is not a recommendation.

Questions about Apollo Hospitals Enterprise Limited

What is the share price of Apollo Hospitals Enterprise Limited today?

Apollo Hospitals Enterprise Limited (APOLLOHOSP) last traded at ₹7,890.00 on NSE (16 Oct 2026, 3:28 PM IST). Prices may be delayed.

What is the market cap of Apollo Hospitals Enterprise Limited?

About ₹1,13,446 crore at the latest price.

What is the P/E ratio of Apollo Hospitals Enterprise Limited?

About 54.3 times its earnings over the last 12 months.

Is Apollo Hospitals Enterprise Limited a good investment?

We do not give views on individual shares. Whether any share suits you depends on your goals, time horizon and risk appetite; for long-term goals, a diversified mutual fund is often a simpler way to own shares. Investments in securities markets are subject to market risks.

How can I buy Apollo Hospitals Enterprise Limited shares?

You need a trading and demat account with a SEBI-registered stock broker. We can help you open one through Parshvanath Investments, an Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539). We provide execution and account service only, not tips or research.

Important. Prices from NSE via Yahoo Finance. Quarterly and annual results, shareholding and documents are taken from the filings the company made with NSE; balance sheet, cash flow and valuation figures are compiled by Yahoo Finance; ratios are computed by us from them. Figures may be delayed or revised. This page is for information only: it is not research, a recommendation or an offer to buy or sell any security. Investments in securities markets are subject to market risks; read all related documents carefully before investing. Plenitude Connect Private Limited is an AMFI-registered Mutual Fund Distributor (ARN-130934); share broking is offered through Parshvanath Investments, Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539).

Talk to us

Have a question about this topic?

Tell us a little about your situation and an expert will call you back, usually within 2 hours on business days.

Get in touch

We typically respond within 2 hours on business days.

Call us

CA Amit Kumar Jain+91 93522 44475 Arihant Jain+91 80056 49698 Poornima Jain+91 92525 44475

Email ussupport@plenitude.co.in

WhatsAppChat with an expert

Visit us5C, Laxmi Colony, Near Bohra Ji Ka Bagh, Opp. Laxmi Mandir Cinema, Tonk Road, Jaipur, Rajasthan 302015

Mon–Sat · 10:00 AM – 7:00 PM IST

In your free consultation

A health check of your current investments
A goal-based plan for retirement, education or a home
Ways to save tax that fit your situation
Clear next steps, with zero pressure to invest

2,000+Investors

₹250 Cr+Client assets

15+ yrsExperience

AMFI Registered Mutual Fund Distributor · ARN-130934

Experts are available Mon–Sat, 10 AM – 7 PM

Book your free wealth consultation

100% free
No obligation
Reply within 2 hours

First name *

Last name *

Email *

Phone *

+91

I'm interested in *

Best day for a call

Preferred time

How can we help? (optional)

Upload your portfolio (optional, get a free expert review)Attach your portfolio statement · PDF, Excel or CSV (e.g. CAS), max 10 MB

I consent to being contacted by Plenitude Connect about financial services. My data will be handled as per the Privacy Policy.

Join 2,000+ investors who plan with Plenitude

Your details are private and never shared.

Apollo Hospitals Enterprise Limited share price

Price chart

Quick take

Pros

Cons

AI analysis

About Apollo Hospitals Enterprise Limited

Peer comparison

Quarterly Results

Profit & Loss

Projection — your assumptions

Related party transactions

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Balance Sheet

Cash Flows

Ratios

Shareholding Pattern

Mutual funds & institutions holding Apollo Hospitals Enterprise

Documents

Announcements

Annual reports

Credit ratings

Concalls & investor meets

Key dates

Trade with our broking desk

Latest news

In the news

From the company (NSE)

Questions about Apollo Hospitals Enterprise Limited

Have a question about this topic?

Book your free wealth consultation

Request received!

What happens next